User profiles for Gonzalo S. Nido

Gonzalo S. Nido

Department of Clinical Medicine, University of Bergen
Verified email at uib.no
Cited by 791

[PDF][PDF] The NADPARK study: A randomized phase I trial of nicotinamide riboside supplementation in Parkinson's disease

B Brakedal, C Dölle, F Riemer, Y Ma, GS Nido… - Cell metabolism, 2022 - cell.com
We conducted a double-blinded phase I clinical trial to establish whether nicotinamide
adenine dinucleotide (NAD) replenishment therapy, via oral intake of nicotinamide riboside (NR), …

[HTML][HTML] Defective mitochondrial DNA homeostasis in the substantia nigra in Parkinson disease

…, GS Nido, H Miletic, N Osuagwu, S Kristoffersen… - Nature …, 2016 - nature.com
Increased somatic mitochondrial DNA (mtDNA) mutagenesis causes premature aging in mice,
and mtDNA damage accumulates in the human brain with aging and neurodegenerative …

[HTML][HTML] Genome-wide histone acetylation analysis reveals altered transcriptional regulation in the Parkinson's disease brain

…, OB Tysnes, G Alves, K Haugarvoll, GS Nido… - Molecular …, 2021 - Springer
Background Parkinson’s disease (PD) is a complex, age-related neurodegenerative disorder
of largely unknown etiology. PD is strongly associated with mitochondrial respiratory …

[HTML][HTML] Ultradeep mapping of neuronal mitochondrial deletions in Parkinson's disease

GS Nido, C Dölle, I Flønes, HA Tuppen, G Alves… - Neurobiology of …, 2018 - Elsevier
… Author links open overlay panel Gonzalo S. Nido a b , Christian Dölle a b , Irene Flønes a
b , Helen A. Tuppen c , Guido Alves d e , Ole-Bjørn Tysnes a b , Kristoffer Haugarvoll a b , …

Rare genetic variation in mitochondrial pathways influences the risk for Parkinson's disease

JJ Gaare, GS Nido, P Sztromwasser… - Movement …, 2018 - Wiley Online Library
Background: Mitochondrial dysfunction plays a key role in PD, but the underlying molecular
mechanisms remain unresolved. We hypothesized that the disruption of mitochondrial …

[HTML][HTML] Common gene expression signatures in Parkinson's disease are driven by changes in cell composition

GS Nido, F Dick, L Toker, K Petersen, G Alves… - Acta neuropathologica …, 2020 - Springer
The etiology of Parkinson’s disease is largely unknown. Genome-wide transcriptomic
studies in bulk brain tissue have identified several molecular signatures associated with the …

Quantifying the evolutionary divergence of protein structures: the role of function change and function conservation

…, D Abia, R Méndez, GS Nido… - Proteins: Structure …, 2010 - Wiley Online Library
The molecular clock hypothesis, stating that protein sequences diverge in evolution by
accumulating amino acid substitutions at an almost constant rate, played a major role in the …

No evidence of extensive non-CpG methylation in mtDNA

R Guitton, GS Nido, C Tzoulis - Nucleic Acids Research, 2022 - academic.oup.com
While most research suggests mitochondrial DNA (mtDNA) harbors low or no methylation, a
few studies claim to report evidence of high-level methylation in the mtDNA. The reasons …

[HTML][HTML] Not every estimate counts–evaluation of cell composition estimation approaches in brain bulk tissue data

L Toker, GS Nido, C Tzoulis - Genome Medicine, 2023 - Springer
Background Variation in cell composition can dramatically impact analyses in bulk tissue
samples. A commonly employed approach to mitigate this issue is to adjust statistical models …

[PDF][PDF] Nicotinamide riboside supplementation is not associated with altered methylation homeostasis in Parkinson's disease

…, B Brakedal, K Brügger, K Haugarvoll, GS Nido… - Iscience, 2023 - cell.com
Replenishing nicotinamide adenine dinucleotide (NAD) via supplementation of nicotinamide
riboside (NR) has been shown to confer neuroprotective effects in models of aging and …